BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 19193796)

  • 1. O-linked N-acetylglucosaminylation of Sp1 inhibits the human immunodeficiency virus type 1 promoter.
    Jochmann R; Thurau M; Jung S; Hofmann C; Naschberger E; Kremmer E; Harrer T; Miller M; Schaft N; Stürzl M
    J Virol; 2009 Apr; 83(8):3704-18. PubMed ID: 19193796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 transcriptional silencing caused by TRIM22 inhibition of Sp1 binding to the viral promoter.
    Turrini F; Marelli S; Kajaste-Rudnitski A; Lusic M; Van Lint C; Das AT; Harwig A; Berkhout B; Vicenzi E
    Retrovirology; 2015 Dec; 12():104. PubMed ID: 26683615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semen Exosomes Promote Transcriptional Silencing of HIV-1 by Disrupting NF-κB/Sp1/Tat Circuitry.
    Welch JL; Kaddour H; Schlievert PM; Stapleton JT; Okeoma CM
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30111566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hijacking of the O-GlcNAcZYME complex by the HTLV-1 Tax oncoprotein facilitates viral transcription.
    Groussaud D; Khair M; Tollenaere AI; Waast L; Kuo MS; Mangeney M; Martella C; Fardini Y; Coste S; Souidi M; Benit L; Pique C; Issad T
    PLoS Pathog; 2017 Jul; 13(7):e1006518. PubMed ID: 28742148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
    McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
    Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular specificity of HIV-1 replication can be controlled by LTR sequences.
    Reed-Inderbitzin E; Maury W
    Virology; 2003 Sep; 314(2):680-95. PubMed ID: 14554095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hexamethylbisacetamide and disruption of human immunodeficiency virus type 1 latency in CD4(+) T cells.
    Choudhary SK; Archin NM; Margolis DM
    J Infect Dis; 2008 Apr; 197(8):1162-70. PubMed ID: 18419522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hepatitis B virus X protein induces HIV-1 replication and transcription in synergy with T-cell activation signals: functional roles of NF-kappaB/NF-AT and SP1-binding sites in the HIV-1 long terminal repeat promoter.
    Gómez-Gonzalo M; Carretero M; Rullas J; Lara-Pezzi E; Aramburu J; Berkhout B; Alcamí J; López-Cabrera M
    J Biol Chem; 2001 Sep; 276(38):35435-43. PubMed ID: 11457829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional regulation of HIV-1 LTR during antigen-dependent activation of primary T cells by dendritic cells.
    Tsunetsugu-Yokota Y; Kato T; Yasuda S; Matsuda Z; Suzuki Y; Koyanagi Y; Yamamoto N; Akagawa K; Cho MW; Takemori T
    J Leukoc Biol; 2000 Mar; 67(3):432-40. PubMed ID: 10733105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcription of the human immunodeficiency virus type 1 (HIV-1) promoter in central nervous system cells: effect of YB-1 on expression of the HIV-1 long terminal repeat.
    Sawaya BE; Khalili K; Amini S
    J Gen Virol; 1998 Feb; 79 ( Pt 2)():239-46. PubMed ID: 9472608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
    Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
    J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of virion protein Vpr of human immunodeficiency virus type 1 with cellular transcription factor Sp1 and trans-activation of viral long terminal repeat.
    Wang L; Mukherjee S; Jia F; Narayan O; Zhao LJ
    J Biol Chem; 1995 Oct; 270(43):25564-9. PubMed ID: 7592727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stress-induced expression of the p75 neurotrophin receptor is regulated by O-GlcNAcylation of the Sp1 transcription factor.
    Kommaddi RP; Dickson KM; Barker PA
    J Neurochem; 2011 Feb; 116(3):396-405. PubMed ID: 21105874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunodeficiency viruses containing heterologous enhancer/promoters are replication competent and exhibit different lymphocyte tropisms.
    Chang LJ; McNulty E; Martin M
    J Virol; 1993 Feb; 67(2):743-52. PubMed ID: 8419644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability.
    Yang X; Su K; Roos MD; Chang Q; Paterson AJ; Kudlow JE
    Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6611-6. PubMed ID: 11371615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variable role of the long terminal repeat Sp1-binding sites in human immunodeficiency virus replication in T lymphocytes.
    Parrott C; Seidner T; Duh E; Leonard J; Theodore TS; Buckler-White A; Martin MA; Rabson AB
    J Virol; 1991 Mar; 65(3):1414-9. PubMed ID: 1995951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second-site long terminal repeat (LTR) revertants of replication-defective human immunodeficiency virus: effects of revertant TATA box motifs on virus infectivity, LTR-directed expression, in vitro RNA synthesis, and binding of basal transcription factors TFIID and TFIIA.
    Kashanchi F; Shibata R; Ross EK; Brady JN; Martin MA
    J Virol; 1994 May; 68(5):3298-307. PubMed ID: 8151790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucosamine-induced Sp1 O-GlcNAcylation ameliorates hypoxia-induced SGLT dysfunction in primary cultured renal proximal tubule cells.
    Suh HN; Lee YJ; Kim MO; Ryu JM; Han HJ
    J Cell Physiol; 2014 Oct; 229(10):1557-68. PubMed ID: 24591095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of a human herpesvirus 6 gene segment capable of transactivating the human immunodeficiency virus type 1 long terminal repeat in an Sp1 binding site-dependent manner.
    Wang J; Jones C; Norcross M; Bohnlein E; Razzaque A
    J Virol; 1994 Mar; 68(3):1706-13. PubMed ID: 8107231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posttranslational, reversible O-glycosylation is stimulated by high glucose and mediates plasminogen activator inhibitor-1 gene expression and Sp1 transcriptional activity in glomerular mesangial cells.
    Goldberg HJ; Whiteside CI; Hart GW; Fantus IG
    Endocrinology; 2006 Jan; 147(1):222-31. PubMed ID: 16365142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.